Wilmot offers the most extensive portfolio of clinical trials for gynecologic cancers in the region. In addition to large national treatment trials, Wilmot also offers trials that are available only ...
No Longer Science Fiction, Immunotherapy Offers Second Chances to Patients, New Opportunities for Research
Among today's most promising clinical developments, immunotherapy aims to boost, restore, or improve the body’s natural defenses to fight cancer.
Helping to care for a loved one from miles away is hard, but Wilmot Cancer Institute social worker Sandra Sabatka shares some ideas for how to stay involved.